The genetics of Tourette disorder

Current Opinion in Genetics and Development

Volumn 21, Issue 3, 2011, Pages 302-309

  State, Matthew W ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CONTACTIN; CONTACTIN ASSOCIATED PROTEIN 2; NEUREXIN; NEUREXIN 1; NEUROLIGIN; NEUROLIGIN 4; PROTEIN IMMPL2; SLIT AND TRK LIKE FAMILY MEMBER 1 PROTEIN; UNCLASSIFIED DRUG;

AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; COHORT ANALYSIS; COPY NUMBER VARIATION; FAMILY STUDY; GENE MAPPING; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GILLES DE LA TOURETTE SYNDROME; HUMAN; LINKAGE ANALYSIS; MOLECULAR GENETICS; MOLECULAR PATHOLOGY; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

CHROMOSOME ABERRATIONS; DNA COPY NUMBER VARIATIONS; GENETIC ASSOCIATION STUDIES; GENETIC LINKAGE; HUMANS; TICS; TOURETTE SYNDROME;

EID: 79957627230     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2011.01.007     Document Type: Review

References (91)

1. Robertson M.M., Eapen V., Cavanna A.E. The international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: a cross-cultural perspective. J Psychosom Res 2009, 67:475-483.
2. Robertson M.M. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies. J Psychosom Res 2008, 65:461-472.
3. Robertson M.M. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 2: tentative explanations for differing prevalence figures in GTD, including the possible effects of psychopathology, aetiology, cultural differences, and differing phenotypes. J Psychosom Res 2008, 65:473-486.
4. Pauls D.L., Cohen D.J., Heimbuch R., Detlor J., Kidd K.K. Familial pattern and transmission of Gilles de la Tourette syndrome and multiple tics. Arch Gen Psychiatry 1981, 38:1091-1093.
5. Kidd K.K., Prusoff B.A., Cohen D.J. Familial pattern of Gilles de la Tourette syndrome. Arch Gen Psychiatry 1980, 37:1336-1339.
6. Pauls D.L., Leckman J.F. The inheritance of Gilles de la Tourette's syndrome and associated behaviors. Evidence for autosomal dominant transmission. N Engl J Med 1986, 315:993-997.
7. Sundaram S.K., Huq A.M., Wilson B.J., Chugani H.T. Tourette syndrome is associated with recurrent exonic copy number variants. Neurology 2010, 74:1583-1590.
8. Price R.A., Kidd K.K., Cohen D.J., Pauls D.L., Leckman J.F. A twin study of Tourette syndrome. Arch Gen Psychiatry 1985, 42:815-820.
9. Freeman R.D., Fast D.K., Burd L., Kerbeshian J., Robertson M.M., Sandor P. An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol 2000, 42:436-447.
10. Pauls D.L., Towbin K.E., Leckman J.F., Zahner G.E., Cohen D.J. Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship. Arch Gen Psychiatry 1986, 43:1180-1182.
11. Baron M., Shapiro E., Shapiro A., Rainer J.D. Genetic analysis of Tourette syndrome suggesting major gene effect. Am J Hum Genet 1981, 33:767-775.
12. Jagger J., Prusoff B.A., Cohen D.J., Kidd K.K., Carbonari C.M., John K. The epidemiology of Tourette's syndrome: a pilot study. Schizophr Bull 1982, 8:267-278.
13. Curtis D., Robertson M.M., Gurling H.M. Autosomal dominant gene transmission in a large kindred with Gilles de la Tourette syndrome. Br J Psychiatry 1992, 160:845-849.
14. Walkup J.T., LaBuda M.C., Singer H.S., Brown J., Riddle M.A., Hurko O. Family study and segregation analysis of Tourette syndrome: evidence for a mixed model of inheritance. Am J Hum Genet 1996, 59:684-693.
15. Kurlan R., Eapen V., Stern J., McDermott M.P., Robertson M.M. Bilineal transmission in Tourette's syndrome families. Neurology 1994, 44:2336-2342.
16. Hasstedt S.J., Leppert M., Filloux F., van de Wetering B.J., McMahon W.M. Intermediate inheritance of Tourette syndrome, assuming assortative mating. Am J Hum Genet 1995, 57:682-689.
17. Hanna P.A., Janjua F.N., Contant C.F., Jankovic J. Bilineal transmission in Tourette syndrome. Neurology 1999, 53:813-818.
18. McMahon W.M., van de Wetering B.J., Filloux F., Betit K., Coon H., Leppert M. Bilineal transmission and phenotypic variation of Tourette's disorder in a large pedigree. J Am Acad Child Adolesc Psychiatry 1996, 35:672-680.
19. Genome scan for Tourette disorder in affected-sibling-pair and multigenerational families. Am J Hum Genet 2007, 80:265-272.
20. A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome. The Tourette Syndrome Association International Consortium for Genetics. Am J Hum Genet 1999, 65:1428-1436.
21. Crane J., Fagerness J., Osiecki L., Gunnell B., Stewart S.E., Pauls D.L., Scharf J.M. Family-based genetic association study of DLGAP3 in Tourette Syndrome. Am J Med Genet B Neuropsychiatr Genet 2010, 156(1):108-114.
22. Herzberg I., Valencia-Duarte A.V., Kay V.A., White D.J., Muller H., Rivas I.C., Mesa S.C., Cuartas M., Garcia J., Bedoya G., et al. Association of DRD2 variants and Gilles de la Tourette syndrome in a family-based sample from a South American population isolate. Psychiatr Genet 2010, 20:179-183.
23. Chou I.C., Lin H.C., Wang C.H., Lin W.D., Lee C.C., Tsai C.H., Tsai F.J. Polymorphisms of interleukin 1 gene IL1RN are associated with Tourette syndrome. Pediatr Neurol 2010, 42:320-324.
24. Miranda D.M., Wigg K., Kabia E.M., Feng Y., Sandor P., Barr C.L. Association of SLITRK1 to Gilles de la Tourette syndrome. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:483-486.
25. Kindler J., Schosser A., Stamenkovic M., Schloegelhofer M., Leisch F., Hornik K., Aschauer H., Gasche C. Tourette's syndrome is not associated with interleukin-10 receptor 1 variants on chromosome 11q23.3. Psychiatry Res 2008, 157:235-239.
26. Miranda D.M., Wigg K., Feng Y., Sandor P., Barr C.L. Association study between Gilles de la Tourette syndrome and two genes in the Robo-Slit pathway located in the chromosome 11q24 linked/associated region. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:68-72.
27. Riviere J.B., St-Onge J., Gaspar C., Diab S., Dion Y., Lesperance P., Tellier G., Richer F., Chouinard S., Dube M.P., et al. Genome-wide TDT analysis in French-Canadian families with Tourette syndrome. Can J Neurol Sci 2010, 37:110-112.
28. State M.W. The genetics of child psychiatric disorders: focus on autism and Tourette syndrome. Neuron 2010, 68:254-269.
29. Shelley B.P., Robertson M.M., Turk J. An individual with Gilles de la Tourette syndrome and Smith-Magenis microdeletion syndrome: is chromosome 17p11. 2 a candidate region for Tourette syndrome putative susceptibility genes?. J Intellect Disabil Res 2007, 51:620-624.
30. Robertson M.M., Shelley B.P., Dalwai S., Brewer C., Critchley H.D. A patient with both Gilles de la Tourette's syndrome and chromosome 22q11 deletion syndrome: clue to the genetics of Gilles de la Tourette's syndrome?. J Psychosom Res 2006, 61:365-368.
31. Clarke R.A., Fang Z.M., Diwan A.D., Gilbert D.L. Tourette syndrome and klippel-feil anomaly in a child with chromosome 22q11 duplication. Case Report Med 2009, 2009:361518.
32. Petek E., Windpassinger C., Vincent J.B., Cheung J., Boright A.P., Scherer S.W., Kroisel P.M., Wagner K. Disruption of a novel gene (IMMP2L) by a breakpoint in 7q31 associated with Tourette syndrome. Am J Hum Genet 2001, 68:848-858.
33. Kroisel P.M., Petek E., Emberger W., Windpassinger C., Wladika W., Wagner K. Candidate region for Gilles de la Tourette syndrome at 7q31. Am J Med Genet 2001, 101:259-261.
34. State M.W., Greally J.M., Cuker A., Bowers P.N., Henegariu O., Morgan T.M., Gunel M., DiLuna M., King R.A., Nelson C., et al. Epigenetic abnormalities associated with a chromosome 18(q21-q22) inversion and a Gilles de la Tourette syndrome phenotype. Proc Natl Acad Sci U S A 2003, 100:4684-4689.
35. Crawford F.C., Ait-Ghezala G., Morris M., Sutcliffe M.J., Hauser R.A., Silver A.A., Mullan M.J. Translocation breakpoint in two unrelated Tourette syndrome cases, within a region previously linked to the disorder. Hum Genet 2003, 113:154-161.
36. Cuker A., State M.W., King R.A., Davis N., Ward D.C. Candidate locus for Gilles de la Tourette syndrome/obsessive compulsive disorder/chronic tic disorder at 18q22. Am J Med Genet A 2004, 130A:37-39.
37. Petek E., Schwarzbraun T., Noor A., Patel M., Nakabayashi K., Choufani S., Windpassinger C., Stamenkovic M., Robertson M.M., Aschauer H.N., et al. Molecular and genomic studies of IMMP2L and mutation screening in autism and Tourette syndrome. Mol Genet Genomics 2007, 277:71-81.
38. Abelson J.F., Kwan K.Y., O'Roak B.J., Baek D.Y., Stillman A.A., Morgan T.M., Mathews C.A., Pauls D.L., Rasin M.R., Gunel M., et al. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005, 310:317-320.
39. Aruga J., Mikoshiba K. Identification and characterization of Slitrk, a novel neuronal transmembrane protein family controlling neurite outgrowth. Mol Cell Neurosci 2003, 24:117-129.
40. Stillman A.A., Krsnik Z., Sun J., Rasin M.R., State M.W., Sestan N., Louvi A. Developmentally regulated and evolutionarily conserved expression of SLITRK1 in brain circuits implicated in Tourette syndrome. J Comp Neurol 2009, 513:21-37.
41. Kajiwara Y., Buxbaum J.D., Grice D.E. SLITRK1 binds 14-3-3 and regulates neurite outgrowth in a phosphorylation-dependent manner. Biol Psychiatry 2009, 66:918-925.
42. Katayama K., Yamada K., Ornthanalai V.G., Inoue T., Ota M., Murphy N.P., Aruga J. Slitrk1-deficient mice display elevated anxiety-like behavior and noradrenergic abnormalities. Mol Psychiatry 2010, 15:177-184.
43. Leckman J.F., Goodman W.K., Anderson G.M., Riddle M.A., Chappell P.B., McSwiggan-Hardin M.T., McDougle C.J., Scahill L.D., Ort S.I., Pauls D.L., et al. Cerebrospinal fluid biogenic amines in obsessive compulsive disorder. Tourette's syndrome, and healthy controls. Neuropsychopharmacology 1995, 12:73-86.
44. Shmelkov S.V., Hormigo A., Jing D., Proenca C.C., Bath K.G., Milde T., Shmelkov E., Kushner J.S., Baljevic M., Dincheva I., et al. Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice. Nat Med 2010, 16:598-602. 591p following 602.
45. Zimprich A., Hatala K., Riederer F., Stogmann E., Aschauer H.N., Stamenkovic M. Sequence analysis of the complete SLITRK1 gene in Austrian patients with Tourette's disorder. Psychiatr Genet 2008, 18:308-309.
46. Chou I.C., Wan L., Liu S.C., Tsai C.H., Tsai F.J. Association of the Slit and Trk-like 1 gene in Taiwanese patients with Tourette syndrome. Pediatr Neurol 2007, 37:404-406.
47. Deng H., Le W.D., Xie W.J., Jankovic J. Examination of the SLITRK1 gene in Caucasian patients with Tourette syndrome. Acta Neurol Scand 2006, 114:400-402.
48. Scharf J.M., Moorjani P., Fagerness J., Platko J.V., Illmann C., Galloway B., Jenike E., Stewart S.E., Pauls D.L. Lack of association between SLITRK1var321 and Tourette syndrome in a large family-based sample. Neurology 2008, 70:1495-1496.
49. Keen-Kim D., Mathews C.A., Reus V.I., Lowe T.L., Herrera L.D., Budman C.L., Gross-Tsur V., Pulver A.E., Bruun R.D., Erenberg G., et al. Overrepresentation of rare variants in a specific ethnic group may confuse interpretation of association analyses. Hum Mol Genet 2006, 15:3324-3328.
50. O'Roak B.J., Morgan T.M., Fishman D.O., Saus E., Alonso P., Gratacos M., Estivill X., Teltsh O., Kohn Y., Kidd K.K., et al. Additional support for the association of SLITRK1 var321 and Tourette syndrome. Mol Psychiatry 2010, 15:447-450.
51. Verkerk A.J., Mathews C.A., Joosse M., Eussen B.H., Heutink P., Oostra B.A. CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. Genomics 2003, 82:1-9.
52. Lawson-Yuen A., Saldivar J.S., Sommer S., Picker J. Familial deletion within NLGN4 associated with autism and Tourette syndrome. Eur J Hum Genet 2008, 16:614-618.
53. Jamain S., Quach H., Betancur C., Rastam M., Colineaux C., Gillberg I.C., Soderstrom H., Giros B., Leboyer M., Gillberg C., et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003, 34:27-29.
54. Laumonnier F., Bonnet-Brilhault F., Gomot M., Blanc R., David A., Moizard M.P., Raynaud M., Ronce N., Lemonnier E., Calvas P., et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 2004, 74:552-557.
55. Strauss K.A., Puffenberger E.G., Huentelman M.J., Gottlieb S., Dobrin S.E., Parod J.M., Stephan D.A., Morton D.H. Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N Engl J Med 2006, 354:1370-1377.
56. Bakkaloglu B., O'Roak B.J., Louvi A., Gupta A.R., Abelson J.F., Morgan T.M., Chawarska K., Klin A., Ercan-Sencicek A.G., Stillman A.A., et al. Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am J Hum Genet 2008, 82:165-173.
57. Alarcon M., Abrahams B.S., Stone J.L., Duvall J.A., Perederiy J.V., Bomar J.M., Sebat J., Wigler M., Martin C.L., Ledbetter D.H., et al. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet 2008, 82:150-159.
58. Arking D.E., Cutler D.J., Brune C.W., Teslovich T.M., West K., Ikeda M., Rea A., Guy M., Lin S., Cook E.H., et al. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet 2008, 82:160-164.
59. Scott-Van Zeeland A.A., Abrahams B.S., Alvarez-Retuerto A.I., Sonnenblick L.I., Rudie J.D., Ghahremani D., Mumford J.A., Poldrack R.A., Dapretto M., Geschwind D.H., et al. Altered functional connectivity in frontal lobe circuits is associated with variation in the autism risk gene CNTNAP2. Sci Transl Med 2010, 2:56ra80.
60. Zweier C., de Jong E.K., Zweier M., Orrico A., Ousager L.B., Collins A.L., Bijlsma E.K., Oortveld M.A., Ekici A.B., Reis A., et al. CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. Am J Hum Genet 2009, 85:655-666.
61. Wang K.S., Liu X.F., Aragam N. A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder. Schizophr Res 2010, 124:192-199.
62. Blake D.J., Forrest M., Chapman R.M., Tinsley C.L., O'Donovan M.C., Owen M.J. TCF4, schizophrenia, and Pitt-Hopkins Syndrome. Schizophr Bull 2010, 36:443-447.
63. Friedman J.I., Vrijenhoek T., Markx S., Janssen I.M., van der Vliet W.A., Faas B.H., Knoers N.V., Cahn W., Kahn R.S., Edelmann L., et al. CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry 2008, 13:261-266.
64. Breedveld G.J., Fabbrini G., Oostra B.A., Berardelli A., Bonifati V. Tourette disorder spectrum maps to chromosome 14q31.1 in an Italian kindred. Neurogenetics 2010, 11:417-423.
65. Merette C., Brassard A., Potvin A., Bouvier H., Rousseau F., Emond C., Bissonnette L., Roy M.A., Maziade M., Ott J., et al. Significant linkage for Tourette syndrome in a large French Canadian family. Am J Hum Genet 2000, 67:1008-1013. See the annotation in Ref. [64•].
66. Laurin N., Wigg K.G., Feng Y., Sandor P., Barr C.L. Chromosome 5 and Gilles de la Tourette syndrome: linkage in a large pedigree and association study of six candidates in the region. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:95-103. See the annotation in Ref. [64•].
67. Knight S., Coon H., Johnson M., Leppert M.F., Camp N.J., McMahon W.M. Linkage analysis of Tourette syndrome in a large Utah pedigree. Am J Med Genet B Neuropsychiatr Genet 2009, 153B(2):656-662. See the annotation in Ref. [64•].
68. Verkerk A.J., Cath D.C., van der Linde H.C., Both J., Heutink P., Breedveld G., Aulchenko Y.S., Oostra B.A. Genetic and clinical analysis of a large Dutch Gilles de la Tourette family. Mol Psychiatry 2006, 11:954-964. See the annotation in Ref. [64•].
69. Curtis D., Brett P., Dearlove A.M., McQuillin A., Kalsi G., Robertson M.M., Gurling H.M. Genome scan of Tourette syndrome in a single large pedigree shows some support for linkage to regions of chromosomes 5, 10 and 13. Psychiatr Genet 2004, 14:83-87. See the annotation in Ref. [64•].
70. Ercan-Sencicek A.G., Stillman A.A., Ghosh A.K., Bilguvar K., O'Roak B.J., Mason C.E., Abbott T., Gupta A., King R.A., Pauls D.L., et al. l-Histidine decarboxylase and Tourette's syndrome. N Engl J Med 2010, 362:1901-1908.
71. Haas H.L., Sergeeva O.A., Selbach O. Histamine in the nervous system. Physiol Rev 2008, 88:1183-1241.
72. Kubota Y., Ito C., Sakurai E., Watanabe T., Ohtsu H. Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice. J Neurochem 2002, 83:837-845.
73. Saka E., Graybiel A.M. Pathophysiology of Tourette's syndrome: striatal pathways revisited. Brain Dev 2003, 25(Suppl 1):S15-19.
74. Esbenshade T.A., Fox G.B., Cowart M.D. Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders. Mol Interv 2006, 6:77-88. 59.
75. Ching M.S., Shen Y., Tan W.H., Jeste S.S., Morrow E.M., Chen X., Mukaddes N.M., Yoo S.Y., Hanson E., Hundley R., et al. Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders. Am J Med Genet B Neuropsychiatr Genet 2010, 153B:937-947.
76. Kirov G., Rujescu D., Ingason A., Collier D.A., O'Donovan M.C., Owen M.J. Neurexin 1 (NRXN1) deletions in schizophrenia. Schizophr Bull 2009, 35:851-854.
77. Rujescu D., Ingason A., Cichon S., Pietilainen O.P., Barnes M.R., Toulopoulou T., Picchioni M., Vassos E., Ettinger U., Bramon E., et al. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet 2009, 18:988-996.
78. Shah A.K., Tioleco N.M., Nolan K., Locker J., Groh K., Villa C., Stopkova P., Pedrosa E., Lachman H.M. Rare NRXN1 promoter variants in patients with schizophrenia. Neurosci Lett 2010, 475:80-84.
79. Kim H.G., Kishikawa S., Higgins A.W., Seong I.S., Donovan D.J., Shen Y., Lally E., Weiss L.A., Najm J., Kutsche K., et al. Disruption of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet 2008, 82:199-207.
80. Yan J., Noltner K., Feng J., Li W., Schroer R., Skinner C., Zeng W., Schwartz C.E., Sommer S.S. Neurexin 1alpha structural variants associated with autism. Neurosci Lett 2008, 438:368-370.
81. Szatmari P., Paterson A.D., Zwaigenbaum L., Roberts W., Brian J., Liu X.Q., Vincent J.B., Skaug J.L., Thompson A.P., Senman L., et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 2007, 39:319-328.
82. Bucan M., Abrahams B.S., Wang K., Glessner J.T., Herman E.I., Sonnenblick L.I., Alvarez Retuerto A.I., Imielinski M., Hadley D., Bradfield J.P., et al. Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet 2009, 5:e1000536.
83. Glessner J.T., Wang K., Cai G., Korvatska O., Kim C.E., Wood S., Zhang H., Estes A., Brune C.W., Bradfield J.P., et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009, 459:569-573.
84. Maestrini E., Pagnamenta A.T., Lamb J.A., Bacchelli E., Sykes N.H., Sousa I., Toma C., Barnby G., Butler H., Winchester L., et al. High-density SNP association study and copy number variation analysis of the AUTD1 and AUTD5 loci implicate the IMMP2L-DOCK4 gene region in autism susceptibility. Mol Psychiatry 2010, 15:954-968.
85. Pagnamenta A.T., Bacchelli E., de Jonge M.V., Mirza G., Scerri T.D., Minopoli F., Chiocchetti A., Ludwig K.U., Hoffmann P., Paracchini S., et al. Characterization of a family with rare deletions in CNTNAP5 and DOCK4 suggests novel risk loci for autism and dyslexia. Biol Psychiatry 2010, 68:320-328.
86. Elia J., Gai X., Xie H.M., Perin J.C., Geiger E., Glessner J.T., D'Arcy M., deBerardinis R., Frackelton E., Kim C., et al. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry 2010, 15:637-646.
87. Mefford H.C., Muhle H., Ostertag P., von Spiczak S., Buysse K., Baker C., Franke A., Malafosse A., Genton P., Thomas P., et al. Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genet 2010, 6:e1000962.
88. Ikeda M., Aleksic B., Kirov G., Kinoshita Y., Yamanouchi Y., Kitajima T., Kawashima K., Okochi T., Kishi T., Zaharieva I., et al. Copy number variation in schizophrenia in the Japanese population. Biol Psychiatry 2010, 67:283-286.
89. Stefansson H., Rujescu D., Cichon S., Pietilainen O.P., Ingason A., Steinberg S., Fossdal R., Sigurdsson E., Sigmundsson T., Buizer-Voskamp J.E., et al. Large recurrent microdeletions associated with schizophrenia. Nature 2008, 455:232-236.
90. Brunetti-Pierri N., Berg J.S., Scaglia F., Belmont J., Bacino C.A., Sahoo T., Lalani S.R., Graham B., Lee B., Shinawi M., et al. Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet 2008, 40:1466-1471.
91. International Schizophrenia Consortium Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008, 455:237-241.